20 related articles for article (PubMed ID: 26003492)
1. Lentiviral vector followed by protein immunisation breaks tolerance against the self-antigen Her1 and results in lung cancer immunotherapy.
Alpizar YA; Karwacz K; Arce F; Yglesias Rivera A; Fernández LE; Collins MK; Sánchez Ramírez B
J Gene Med; 2012 Mar; 14(3):151-7. PubMed ID: 22262303
[TBL] [Abstract][Full Text] [Related]
2. HEK293 producing the extracellular domain HER1: Full datasets of continuous fermentation process and metabolites analysis.
Calzadilla L; Hernández E; Dustet J; Fernandez-de-Cossio-Diaz J; León K; Pietzke M; Vazquez A; Mulet R; Boggiano T
Data Brief; 2023 Oct; 50():109604. PubMed ID: 37808545
[TBL] [Abstract][Full Text] [Related]
3. Sodium acetate increases the productivity of HEK293 cells expressing the ECD-Her1 protein in batch cultures: experimental results and metabolic flux analysis.
Pérez-Fernández BA; Calzadilla L; Enrico Bena C; Del Giudice M; Bosia C; Boggiano T; Mulet R
Front Bioeng Biotechnol; 2024; 12():1335898. PubMed ID: 38659646
[TBL] [Abstract][Full Text] [Related]
4. Purification process development for HER1 extracellular domain as a potential therapeutic vaccine.
León D; Prieto Y; Fernández EG; Pérez N; Montero JA; Palacios J; Bulté D; de la Luz KR; Peña V; Ferro W; Sánchez B; Valdés R; Castillo A
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3105-10. PubMed ID: 19700375
[TBL] [Abstract][Full Text] [Related]
5. Active antimetastatic immunotherapy in Lewis lung carcinoma with self EGFR extracellular domain protein in VSSP adjuvant.
Ramírez BS; Pestana ES; Hidalgo GG; García TH; Rodríguez RP; Ullrich A; Férnandez LE
Int J Cancer; 2006 Nov; 119(9):2190-9. PubMed ID: 16841332
[TBL] [Abstract][Full Text] [Related]
6. Non-clinical immuno-toxicological evaluation of HER1 cancer vaccine in non-human primates: a 12-month study.
Barro AM; Rivero AI; Goñi AL; Navarro BO; Angarica MM; Ramírez BS; Bedoya DM; Triana CG; Rodríguez AM; Parada ÁC
Vaccine; 2012 Dec; 31(1):89-95. PubMed ID: 23142132
[TBL] [Abstract][Full Text] [Related]
7. B-cell epitope peptide vaccination targeting dimer interface of epidermal growth factor receptor (EGFR).
Zhu L; Zhao L; Wu M; Chen Z; Li H
Immunol Lett; 2013 Jun; 153(1-2):33-40. PubMed ID: 23871733
[TBL] [Abstract][Full Text] [Related]
8. Expression and purification of the extracellular ligand-binding domain of the atrial natriuretic peptide (ANP) receptor: monovalent binding with ANP induces 2:2 complexes.
Misono KS; Sivasubramanian N; Berkner K; Zhang X
Biochemistry; 1999 Jan; 38(2):516-23. PubMed ID: 9888790
[TBL] [Abstract][Full Text] [Related]
9. An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).
Ferrer-Soler L; Vazquez-Martin A; Brunet J; Menendez JA; De Llorens R; Colomer R
Int J Mol Med; 2007 Jul; 20(1):3-10. PubMed ID: 17549382
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the impact of manufacturing changes on the physicochemical properties and biological activity of Her1-ECD vaccine during product development.
Garcia Duardo K; Prieto Curbelo Y; Raymond Pous J; Rabasa Legón EY; Ramírez BS; Hernández KR; Castillo Vitoch A
Vaccine; 2015 Aug; 33(35):4292-9. PubMed ID: 26003492
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
